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Measurement-Based Treatment to Target
for Depression: Use of PHQ-9 in Primary
Care.
Poone Haghani Tehrani, MD

Introduction:
• Measurement-based treatment: use of
screeners like HbA1c or PHQ9 for diagnosing
and monitoring health conditions like diabetes
and depression.
• PHQ9: depression screener, well validated,
free, and shows which specific symptoms of
depression are or are not improving.
• Treatment to Target: to adjust treatment in
order to achieve response (50% reduction in
symptom measures.)
• Treatment to Target prevents treatment inertia:
both provider and patient will know if the
patient is having a full response, partial
response, or no response.

Methods:
• A 20-min education was provided to primary
care providers.
• A pre- and post-education anonymous survey
was conducted.

Results:
The survey indicated that providers used PHQ9
more often after the educational session.

Conclusion:
The data suggests that provider awareness of the
advantages of using the PHQ9 could increase
primary care providers’ use of it in screening for
and monitoring depression.

Provider awareness of the
advantages of using the PHQ9
could increase primary care
providers’ use of it in screening
for and monitoring depression.

The response rate was 77.7% for
the pre-education survey and
100% for the post-education
survey (2 of the providers
relocated before the post-education
survey.)
Content of the 20-min educational
session:
• Evidence in support of
measurement-based treatment to
target.
• Advantages of the PHQ9.
• Specific examples of providers’
patients who benefitted from use
of PHQ9.

